295 related articles for article (PubMed ID: 31246249)
1. Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult Smokers.
Aldrich MC; Mercaldo SF; Sandler KL; Blot WJ; Grogan EL; Blume JD
JAMA Oncol; 2019 Sep; 5(9):1318-1324. PubMed ID: 31246249
[TBL] [Abstract][Full Text] [Related]
2. Comparison Between the 2021 USPSTF Lung Cancer Screening Criteria and Other Lung Cancer Screening Criteria for Racial Disparity in Eligibility.
Pu CY; Lusk CM; Neslund-Dudas C; Gadgeel S; Soubani AO; Schwartz AG
JAMA Oncol; 2022 Mar; 8(3):374-382. PubMed ID: 35024781
[TBL] [Abstract][Full Text] [Related]
3. Risk Model-Based Lung Cancer Screening and Racial and Ethnic Disparities in the US.
Choi E; Ding VY; Luo SJ; Ten Haaf K; Wu JT; Aredo JV; Wilkens LR; Freedman ND; Backhus LM; Leung AN; Meza R; Lui NS; Haiman CA; Park SL; Le Marchand L; Neal JW; Cheng I; Wakelee HA; Tammemägi MC; Han SS
JAMA Oncol; 2023 Dec; 9(12):1640-1648. PubMed ID: 37883107
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Eligibility for Lung Cancer Screening by Race After 2021 Changes to US Preventive Services Task Force Screening Guidelines.
Pinheiro LC; Groner L; Soroka O; Prosper AE; Jack K; Tamimi RM; Safford M; Phillips E
JAMA Netw Open; 2022 Sep; 5(9):e2229741. PubMed ID: 36053535
[TBL] [Abstract][Full Text] [Related]
5. Risk Prediction Model Versus United States Preventive Services Task Force Lung Cancer Screening Eligibility Criteria: Reducing Race Disparities.
Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE
J Thorac Oncol; 2020 Nov; 15(11):1738-1747. PubMed ID: 32822843
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.
Meza R; Jeon J; Toumazis I; Ten Haaf K; Cao P; Bastani M; Han SS; Blom EF; Jonas DE; Feuer EJ; Plevritis SK; de Koning HJ; Kong CY
JAMA; 2021 Mar; 325(10):988-997. PubMed ID: 33687469
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening.
Toumazis I; de Nijs K; Cao P; Bastani M; Munshi V; Ten Haaf K; Jeon J; Gazelle GS; Feuer EJ; de Koning HJ; Meza R; Kong CY; Han SS; Plevritis SK
JAMA Oncol; 2021 Dec; 7(12):1833-1842. PubMed ID: 34673885
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not Recommended.
Faselis C; Nations JA; Morgan CJ; Antevil J; Roseman JM; Zhang S; Fonarow GC; Sheriff HM; Trachiotis GD; Allman RM; Deedwania P; Zeng-Trietler Q; Taub DD; Ahmed AA; Howard G; Ahmed A
JAMA Oncol; 2022 Oct; 8(10):1428-1437. PubMed ID: 35900734
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Revised US Preventive Services Task Force Lung Cancer Screening Guideline Among Women and Racial/Ethnic Minority Populations.
Reese TJ; Schlechter CR; Potter LN; Kawamoto K; Del Fiol G; Lam CY; Wetter DW
JAMA Netw Open; 2021 Jan; 4(1):e2033769. PubMed ID: 33433600
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems.
Ritzwoller DP; Meza R; Carroll NM; Blum-Barnett E; Burnett-Hartman AN; Greenlee RT; Honda SA; Neslund-Dudas C; Rendle KA; Vachani A
JAMA Netw Open; 2021 Oct; 4(10):e2128176. PubMed ID: 34636916
[TBL] [Abstract][Full Text] [Related]
11. Racial and Ethnic Disparities in Lung Cancer Screening by the 2021 USPSTF Guidelines Versus Risk-Based Criteria: The Multiethnic Cohort Study.
Aredo JV; Choi E; Ding VY; Tammemägi MC; Ten Haaf K; Luo SJ; Freedman ND; Wilkens LR; Le Marchand L; Wakelee HA; Meza R; Park SL; Cheng I; Han SS
JNCI Cancer Spectr; 2022 May; 6(3):. PubMed ID: 35642317
[TBL] [Abstract][Full Text] [Related]
12. Pack-Year Smoking History: An Inadequate and Biased Measure to Determine Lung Cancer Screening Eligibility.
Potter AL; Xu NN; Senthil P; Srinivasan D; Lee H; Gazelle GS; Chelala L; Zheng W; Fintelmann FJ; Sequist LV; Donington J; Palmer JR; Yang CJ
J Clin Oncol; 2024 Jun; 42(17):2026-2037. PubMed ID: 38537159
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.
Katki HA; Kovalchik SA; Berg CD; Cheung LC; Chaturvedi AK
JAMA; 2016 Jun; 315(21):2300-11. PubMed ID: 27179989
[TBL] [Abstract][Full Text] [Related]
14. 5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study.
Luo YH; Luo L; Wampfler JA; Wang Y; Liu D; Chen YM; Adjei AA; Midthun DE; Yang P
Lancet Oncol; 2019 Aug; 20(8):1098-1108. PubMed ID: 31255490
[TBL] [Abstract][Full Text] [Related]
15. Racial disparities in eligibility for low-dose computed tomography lung cancer screening among older adults with a history of smoking.
Li CC; Matthews AK; Rywant MM; Hallgren E; Shah RC
Cancer Causes Control; 2019 Mar; 30(3):235-240. PubMed ID: 30377905
[TBL] [Abstract][Full Text] [Related]
16. Lung Cancer Screening in Brazil Comparing the 2013 and 2021 USPSTF Guidelines.
Emmerick ICM; Campos MR; Castanheira D; Muzy J; Marques A; Arueira Chaves L; Sobreira da Silva MJ
JAMA Netw Open; 2023 Dec; 6(12):e2346994. PubMed ID: 38079172
[TBL] [Abstract][Full Text] [Related]
17. Incorporating both genetic and tobacco smoking data to identify high-risk smokers for lung cancer screening.
Jia G; Wen W; Massion PP; Shu XO; Zheng W
Carcinogenesis; 2021 Jun; 42(6):874-879. PubMed ID: 33640962
[TBL] [Abstract][Full Text] [Related]
18. Racial and Ethnic Disparities in Lung Cancer Screening Eligibility.
Narayan AK; Chowdhry DN; Fintelmann FJ; Little BP; Shepard JO; Flores EJ
Radiology; 2021 Dec; 301(3):712-720. PubMed ID: 34546133
[TBL] [Abstract][Full Text] [Related]
19. Addressing Sex Disparities in Lung Cancer Screening Eligibility: USPSTF vs PLCOm2012 Criteria.
Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Guzman A; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE
Chest; 2022 Jan; 161(1):248-256. PubMed ID: 34252436
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
